Masitinib Plus Gemcitabine in Pancreatic Cancer
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03766295 |
|
Recruitment Status :
Completed
First Posted : December 6, 2018
Last Update Posted : December 8, 2020
|
Sponsor:
AB Science
Information provided by (Responsible Party):
AB Science
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Completed |
|---|---|
| Actual Primary Completion Date : | December 2020 |
| Actual Study Completion Date : | December 2020 |
| Certification/Extension First Submitted : | December 7, 2020 |